Docetaxel Shows Radiosenstization in SMMC-7721 Human Hepatocellular Carcinoma Cells

耿长新,曾昭冲,王吉耀

DOI: https://doi.org/10.3969/j.issn.1672-8467.2003.03.020

2003-01-01

Abstract:Purpose To determine the radiosensitizing potential of docetaxel in human hepatocellular car-cinoma(HCC) SMMC-7721 cells. Methods SMMC-7721 cells were incubated with docetaxel at 0.125, 0.25,0.5 nmol/L for 24 hr and at 0.125,0.25 nmol/L for 48 hr before irradiation. Radiation doses were given from 0 to 10 Gy. Cell survival was measured by a standard clonogenic assay after a 9 day incubation. The reactive oxygen species( ROS) and glutathione( GSH) were detected after the cells were given the same dose of docetaxel for the same time. Results The sensitization enhancement ratios(SERDq) for SMMC-7721 cells determined were 1.12,1.19,1.43 at 0.125,0.25,0.5 nmol/L for pre-incubation 24 hr, respectively; the SERDq, were 1. 37,1. 48 at 0. 125,0. 25 nmol/L for pre-incubation 48 hr, respectively. The SMMC-7721 cells ROS increased and GSH decreased after pretreatment with the same doses of docetaxel for 24 hr or 48 hr. Conclusions A radiosensitizing effect of docetaxel could be demonstrated unambiguously in this cell line used. In addition,our data show that the mechanism of radiopotentiation by docetaxel probably does not involve a G2/M block in SMMC-7721 cells,and ROS generation and GSH deletion may play a key role in the radiosensitizing effect of docetaxel.